Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

4.2K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.2K
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

2.5K
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
2.5K
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

2.9K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
2.9K
Bioequivalence: Overview01:16

Bioequivalence: Overview

921
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
921
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

142
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
142
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

2.6K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changes in serum TSH across the adult lifespan: 22-year follow-up of the HUNT Study.

European journal of endocrinology·2026
Same author

UK Foundation Programme training needs a national minimum standard for advanced life support.

Clinical medicine (London, England)·2026
Same author

What Endocrinologists Should Know About Iodine: Population Deficiency, Individual Excess and Misinformation in the United Kingdom.

Clinical endocrinology·2026
Same author

Frameworks to Evaluate the Quality of Public Involvement in Health and Social Care Research: A Scoping Review.

Health expectations : an international journal of public participation in health care and health policy·2026
Same author

Improving awareness and care in polyendocrine metabolic ovarian syndrome (formerly polycystic ovary syndrome).

BMJ (Clinical research ed.)·2026
Same author

Serial Dried Blood Spot C-Peptide Sampling, but Not Urine C-Peptide-to-Creatinine Ratio, Detects Early Preservation of β-Cell Function in New-Onset Type 1 Diabetes: Experience From the USTEKID Trial.

Diabetes care·2026
Same journal

Supraphysiological Glucocorticoid Doses and Pitfalls of Annual Biomarker Monitoring in Adults With CAH.

Clinical endocrinology·2026
Same journal

Subacute Thyroiditis in Denmark: A Nationwide Study of 1763 Cases.

Clinical endocrinology·2026
Same journal

Pubertal Dynamics of Sertoli and Leydig Cell Dysfunction in Klinefelter Syndrome.

Clinical endocrinology·2026
Same journal

Regarding Non-Classical Presentations of Rare Hereditary Hypoparathyroidism: A Case Series of CASR, GNA11, and GATA3 Mutations in Parathyroidology.

Clinical endocrinology·2026
Same journal

Dual Metabolic Burden of Polyendocrine Metabolic Ovarian Syndrome (PMOS) and Gestational Diabetes in Pregnancy: Impact on Neonatal Anthropometry: Insights From the Born in Bradford Cohort.

Clinical endocrinology·2026
Same journal

Preoperative CALLY Index for Identifying Atypical Parathyroid Tumors.

Clinical endocrinology·2026
See all related articles

Related Experiment Video

Updated: Jun 4, 2025

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

1.6K

How Does Thyroid Hormone Profile Differ on and Off Replacement Treatment?

Adrian H Heald1,2, Lakdasa D Premawardhana3, Peter N Taylor3

  • 1The School of Medicine and Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK.

Clinical Endocrinology
|December 20, 2024
PubMed
Summary
This summary is machine-generated.

Levothyroxine treatment for hypothyroidism often results in higher thyroid-stimulating hormone (TSH) and free T4 (FT4) levels than expected. This suggests current treatment regimens may not optimize thyroid hormone status, particularly in women.

Keywords:
thyroid hormone profiletreated hypothyroidismuntreated and euthyroid individuals

More Related Videos

Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model
04:14

Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model

Published on: October 6, 2023

767
Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:27

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

667

Related Experiment Videos

Last Updated: Jun 4, 2025

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

1.6K
Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model
04:14

Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model

Published on: October 6, 2023

767
Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:27

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

667

Area of Science:

  • Endocrinology
  • Thyroidology
  • Clinical Chemistry

Background:

  • Optimizing thyroid hormone status in hypothyroid patients remains a clinical challenge.
  • Understanding the relationship between free T4 (FT4) and thyroid-stimulating hormone (TSH) is crucial for effective hypothyroidism management.

Purpose of the Study:

  • To analyze the relationship between FT4 and TSH in a large laboratory sample of individuals undergoing thyroid function tests.
  • To compare FT4 and TSH levels in patients on levothyroxine replacement therapy versus those not on treatment.

Main Methods:

  • Retrospective analysis of 290,000 thyroid function tests (TFTs) from 130,000 individuals (2009-2012).
  • Data categorized into treated (levothyroxine) and untreated groups, with specific filtering for comorbidities and single vs. median test results.
  • Cluster analysis used to define expected FT4/TSH ranges (5th-95th percentiles) for untreated individuals and assess deviations in treated patients.

Main Results:

  • Median TSH and FT4 levels were higher in treated patients (TSH: 2.3 mU/L, FT4: 18.9 pmol/L) compared to untreated individuals (TSH: 1.8 mU/L, FT4: 15.5 pmol/L).
  • A significant proportion of treated patients (68%) had results outside the reference range established from untreated patients, with higher TSH and FT4 values.
  • This discordance was more pronounced in women (70%) than men (63%).

Conclusions:

  • Current levothyroxine dosing strategies do not consistently achieve optimal laboratory thyroid function test profiles.
  • A substantial percentage of treated hypothyroid patients exhibit TSH and FT4 levels outside expected ranges, indicating potential undertreatment or suboptimal regimen.
  • The higher prevalence in women suggests potential sex-specific differences in levothyroxine metabolism or response.